US2019046669A1PendingUtilityA1

Systems, methods, and devices for sterilizing antiseptic solutions

Assignee: CAREFUSION 2200 INCPriority: Jan 8, 2014Filed: Oct 18, 2018Published: Feb 14, 2019
Est. expiryJan 8, 2034(~7.4 yrs left)· nominal 20-yr term from priority
A01N 47/44A01N 43/40A61P 31/02A61L 2/04A01N 31/02A61L 2/0023A01N 25/02A61L 2103/05
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for sterilizing an antiseptic solution includes providing a container containing the antiseptic solution, the antiseptic solution having an initial purity, selecting a sterilization temperature from about 85° C. to about 135° C. and an sterilization time from about 1 minute to about 19 hours, heating the antiseptic solution to the selected sterilization temperature, maintaining the temperature for the selected sterilization time, and terminating the heating of the antiseptic solution when the sterilization time expires. After terminating the heating, the antiseptic solution has a post-sterilization purity. The sterilization temperature and the sterilization time are selected such that after terminating the heating, the antiseptic solution is sterile and has a post-sterilization purity of at least about 92% and the percentage point change in purity from the initial purity to the post-sterilization purity is at most about 5%.

Claims

exact text as granted — not AI-modified
1 - 27 . (canceled) 
     
     
         28 . A sterile antiseptic solution comprising:
 an antimicrobial molecule selected from the group consisting of an octenidine salt and a biguanide; and   a solvent,   wherein the sterile antiseptic solution is sterile and at least 92% pure.   
     
     
         29 . The sterile antiseptic solution of  claim 28 , prepared by a method comprising the steps of:
 providing a container containing an antiseptic solution, the antiseptic solution having an initial purity;   selecting a sterilization temperature from about 85° C. to about 135° C. and a sterilization time from about 1 minute to about 19 hours;   heating the antiseptic solution to the selected sterilization temperature;   maintaining the antiseptic solution at the sterilization temperature for the selected sterilization time; and   terminating the heating of the antiseptic solution when the selected sterilization time expires, thereby providing the sterile antiseptic solution,   wherein after terminating the heating, the sterile antiseptic solution has a post-sterilization purity, and   wherein the sterilization temperature and the sterilization time are selected such that after terminating the heating, the sterile antiseptic solution has a post-sterilization purity of at least about 92% and a percentage point change in purity from the initial purity to the post-sterilization purity of at most about 5%.   
     
     
         30 . The sterile antiseptic solution of  claim 29 , wherein the selected sterilization time and selected sterilization temperature satisfy the following relationship:
   85° C.  y< 125° C.,
       y≥− 6.14·ln  x+ 123.2 for 1≤ x≤ 552, and
       y≤− 10.38·ln  x+ 156.9 for 21.5≤ x≤ 1123; or  a)
     125° C.≤ y≤ 135° C.,
       x≥ 1 and       y≤− 10.38·ln  x+ 156.9 for 9.1≤ x≤ 21.5,  b)
   wherein y is the sterilization temperature and x is the sterilization time in minutes.   
     
     
         31 . The sterile antiseptic solution of  claim 29 , wherein the selected sterilization time and selected sterilization temperature satisfy the following relationship:
   85° C.  y< 125° C.,  a)
       y≥− 6.14·ln  x+ 123.2 for 1≤ x≤ 552, and
       y≤− 10.37·ln  x+ 154.6 for 17.5≤ x≤ 900, or  a)
     125° C.≤ y≤ 135° C.,
       x≥ 1 and       y≤− 10.37·ln  x+ 154.6 for 7.3≤ x≤ 17.5,  b)
   wherein y is the sterilization temperature and x is the sterilization time in minutes.   
     
     
         32 . The sterile antiseptic solution of  claim 29 , wherein the selected sterilization time and selected sterilization temperature satisfy the following relationship:
   85° C.  y< 125° C.,
       y≥− 6.14·ln  x+ 123.2 for 1≤ x≤ 552, and
       y≤− 10.4·ln  x+ 151.7 for 13≤ x≤ 670, or  a)
     125° C.≤ y≤ 135° C.,
       x≥ 1 and       y≤− 10.4·ln  x+ 151.7 for 5.5≤ x≤ 13,  b)
   wherein y is the sterilization temperature and x is the sterilization time in minutes.   
     
     
         33 . The sterile antiseptic solution of  claim 29 , wherein the selected sterilization time and selected sterilization temperature satisfy the following relationship:
   90° C.  y< 125° C.,
       y≥− 6.14·ln  x+ 123.2 for 1≤ x≤ 552, and
       y≤− 10.6·ln  x+ 148.3 for 9≤ x≤ 260, or  a)
     125° C.≤ y≤ 135° C.,
       x≥ 1, and       y≤− 10.6·ln  x+ 148.3 for 3.7≤ x≤ 9  b)
   wherein y is the sterilization temperature and x is the sterilization time in minutes.   
     
     
         34 . The sterile antiseptic solution of  claim 29 , wherein the selected sterilization temperature and the selected sterilization time are chosen such that after terminating the heating, the sterile antiseptic solution has a post-sterilization purity of at least about 94% and the percentage point change in purity from the initial purity to the post-sterilization purity is at most about 4%. 
     
     
         35 . The sterile antiseptic solution of  claim 29 , wherein the selected sterilization temperature and the selected sterilization time are chosen such that after terminating the heating, the sterile antiseptic solution has a post-sterilization purity of at least about 96% and the percentage point change in purity from the initial purity to the post-sterilization purity is at most about 3%. 
     
     
         36 . The sterile antiseptic solution of  claim 29 , wherein the selected sterilization temperature and the selected sterilization time are chosen such that after terminating the heating, the sterile antiseptic solution has a post-sterilization purity of at least about 98% and the percentage point change in purity from the initial purity to the post-sterilization purity is at most about 2%. 
     
     
         37 . The sterile antiseptic solution of  claim 28 , wherein the sterile antiseptic solution is completely free of microbes. 
     
     
         38 . The sterile antiseptic solution of  claim 28 , wherein the antimicrobial molecule is selected from the group consisting of chlorhexidine gluconate and octenidine dihydrochloride; and
 wherein the solvent is selected from the group consisting of ethanol, isopropanol, and n-propanol.   
     
     
         39 . The sterile antiseptic solution of  claim 28 , comprising from about 40% to about 90% v/v of the solvent and from about 0.1% to about 2.5% w/v of the antimicrobial molecule, wherein the solvent comprises isopropanol and the antimicrobial molecule comprises chlorhexidine gluconate. 
     
     
         40 . The sterile antiseptic solution of  claim 28 , comprising about 70% v/v of the solvent and about 2.0% w/v of the antimicrobial molecule, wherein the solvent comprises isopropanol and the antimicrobial molecule comprises chlorhexidine gluconate. 
     
     
         41 . The sterile antiseptic solution  claim 29 , wherein the sterilization time is from about 6 minutes to about one hour. 
     
     
         42 . The sterile antiseptic solution of  claim 29 , wherein the sterilization temperature is about 95° C. and the sterilization time is from about 1.5 hours to about 6.5 hours. 
     
     
         43 . The sterile antiseptic solution of  claim 29 , wherein the sterilization temperature is about 110° C. and the sterilization time is from about 6 minutes to about 90 minutes. 
     
     
         44 . The sterile antiseptic solution of  claim 29 , wherein the sterilization temperature is about 120° C. and the sterilization time is from about 2 minutes to about 35 minutes. 
     
     
         45 . The sterile antiseptic solution of  claim 29 , wherein the container comprises glass or plastic. 
     
     
         46 . The sterile antiseptic solution of  claim 29 , wherein the method further comprises the steps of:
 providing a cascading water sterilizer that produces a constant, cascading waterfall,   wherein heating the antiseptic solution to the selected sterilization temperature and maintaining the selected sterilization temperature comprises contacting the container with the cascading waterfall for the duration of the sterilization time.   
     
     
         47 . The sterile antiseptic solution of  claim 29 , wherein the method further comprises a step of cooling the sterile antiseptic solution after terminating the heating. 
     
     
         48 . The sterile antiseptic solution of  claim 29 , wherein prior to heating the solution to the selected sterilization temperature, the container and the antiseptic solution have a temperature from about 20° C. to about 35° C. 
     
     
         49 . The sterile antiseptic solution of  claim 29 , wherein the container is sealed prior to heating the antiseptic solution to the selected sterilization temperature. 
     
     
         50 . The sterile antiseptic solution of  claim 38 , further comprising water. 
     
     
         51 . The sterile antiseptic solution of  claim 28 , wherein the antiseptic solution is at least 94% pure. 
     
     
         52 . The sterile antiseptic solution of  claim 28 , wherein the antiseptic solution is at least 96% pure. 
     
     
         53 . The sterile antiseptic solution of  claim 28 , wherein the antiseptic solution is at least 98% pure. 
     
     
         54 . The sterile antiseptic solution of  claim 28 , comprising from about 40% to about 90% v/v of the solvent, from about 0.1% to about 2.5% w/v of the antimicrobial molecule, and from about 10% to about 60% v/v water, wherein the solvent comprises isopropanol and the antimicrobial molecule comprises chlorhexidine gluconate. 
     
     
         55 . The sterile antiseptic solution of  claim 28 , wherein the sterile antiseptic solution maintains 7-day sterility in accordance with U.S. Pharmacopeia Convention (USP) 36, Chapter 55, Biological Indicators—Resistance Performance Tests.

Join the waitlist — get patent alerts

Track US2019046669A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.